Nav: Home

How often should you have a mammogram? Breast density and risk can inform decision

August 22, 2016

1. Breast density and risk may be useful for guiding mammography screening frequency
Abstract: http://www.annals.org/article.aspx?doi=10.7326/M16-0476
Editorial: http://www.annals.org/article.aspx?doi=10.7326/M16-1791
URLs go live when the embargo lifts

Women between the ages of 50 and 74 may benefit from more or less frequent mammography screening than is generally recommended, depending on breast density and risk. For average-risk women with lower breast density, which comprises a large proportion of the population, triennial screening offers about the same or better balance of benefits and harms as biennial screening and is also cost-effective. Higher-risk women with dense breasts may fare better with annual screening. Findings from a collaborative modeling study are published in Annals of Internal Medicine.

Accepted clinical guidelines recommend biennial mammography screening for women aged 50 to 74. These recommendations also advocate shared decision making regarding screening frequency that takes into consideration an individual woman's preferences, risk level, and breast density. However, there is limited data available to guide clinicians and women in making these decisions.

Researchers from the Cancer Intervention and Surveillance Modeling Network, collaborating with the Breast Cancer Surveillance Consortium (BCSC), used three well-established models to evaluate outcomes using various screening intervals for digital mammography among subgroups of women based on age, risk, and breast density. The outcomes were projected for women 50 or older who were deciding whether to initiate (or continue) biennial screening until age 74 or to have annual or triennial screening. The models showed that average-risk women with lower breast density could safely and effectively extend their screening interval to once every three years, which could reduce false-positives, biopsies, and overdiagnosis with minimal effect on breast cancer deaths averted. Women at higher risk for breast cancer and with dense breasts would reap greater benefit from annual screening. The authors suggest that these findings could be useful for guiding shared decision making and tailoring screening intervals.

Note: For an embargoed PDF, please contact Cara Graeff. To reach the lead author, Dr. Amy Trentham-Dietz, please contact Susan Smith at ssmith5@uwhealth.org or 608-890-5643.




2. Preoperative patient frailty a good predictor of long-term mortality in older patients
Abstract: http://www.annals.org/article.aspx?doi=10.7326/M16-0652
Editorial: http://www.annals.org/article.aspx?doi=10.7326/M16-1866
URLs go live when the embargo lifts

Frailty status, assessed using tools that measure mobility, disability, and nutritional status, may predict mortality 6 or more months after major cardiac surgery and functional decline after more minor cardiac procedures. A systematic evidence review is published in Annals of Internal Medicine.

Identifying patients who are most or least likely to benefit from surgical procedures remains a significant challenge. Frailty is one of the factors that affect outcomes in older patients. As such, experts have developed several instruments to measure frailty by assessing gait speed, grip strength, or deficit accumulation. However, there is no consensus on how to best measure this vulnerability.

Researchers reviewed published studies to evaluate the evidence for 9 frailty instruments used to predict mortality, functional status, or major adverse cardiovascular and cerebrovascular events (MACCEs) in older adults undergoing cardiac surgical procedures and 13 instruments to measure the same in patients undergoing minimally invasive procedures. Despite the various ways of measuring frailty, the researchers found strong evidence that it predicts mortality at 6 months or later after major or minimally invasive procedures. Some evidence indicated that frailty may predict functional decline, poor quality of life, or lack of symptomatic benefit after minimally invasive procedures.

The authors of an accompanying editorial suggest that these findings can improve care for older surgical patients by helping to inform decisions about surgery for both the patient and clinician. Once the decision to have surgery is made, patients and their caregivers can be better prepared for possible outcomes.

Note: For an embargoed PDF, please contact Cara Graeff. The lead author, Dr. Dae Hyun Kim, can be reached through Kelly Lawman at klawman@bidmc.harvard.edu or 617-667-7305.




3. Fecal transplantation seems highly curative for recurrent C. diff, but questions remain
Abstract: http://www.annals.org/article.aspx?doi=10.7326/M16-0271
Editorial: http://www.annals.org/article.aspx?doi=10.7326/M16-1784
URLs go live when the embargo lifts

In a randomized, controlled, double-blind clinical trial, fecal microbiota transplantation using donor stool seemed to be safe and was more efficacious than transplantation using the patient's own stool in curing multiply recurrent Clostridium difficile (C. diff) infection. However, results varied widely by study site, raising questions about the benefits and risk of the procedure. The findings are published in Annals of Internal Medicine.

C. diff is the most common health care-associated infection in U.S. hospitals. Antibiotics are frequently ineffective and recurrences are common. Fecal transplantation restores the normal composition of gut microbiota and is recommended when antibiotics fail to clear the infection after a third episode of infection. However, the evidence for fecal transplantation rests largely on case series and several open-label clinical trials.

Researchers assigned 46 patients with three or more recurrences of C. diff to receive fecal microbiota transplantation with donor stool or their own stool administered by colonoscopy at two academic medical centers - Montefiore Medical Center in the Bronx, New York, and The Miriam Hospital in Providence, Rhode Island. Overall, 91 percent of patients in the donor stool group achieved clinical cure compared with 63 percent receiving their own stool. However, cure rates in patients receiving their own stool were 90 percent in the New York medical center and about 43 percent at the Rhode Island medical center.

The author of an accompanying editorial suggests that these "striking" findings may be due to differences in patient characteristics including, locale, length of time between initial diagnosis and transplantation, and the type of antibiotic used, among other factors. More research is needed to answer some of the questions raised by this randomized trial.

Note: For an embargoed PDF, please contact Angela Collom. The lead author, Dr. Colleen Kelly, please contact Elena Falcone-Relvas at efalconerelvas@lifespan.org or 401-793-7484.
-end-


American College of Physicians

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.